(Q44644573)

5 December 2017

Vascular endothelial growth factor is associated with the efficacy of endocrine therapy in patients with advanced breast carcinoma (English)

1 reference

5 December 2017

1 reference

29 March 2024

4

Paul N. Span

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14601081

29 March 2024

5

C. G J. Sweep

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14601081

29 March 2024

author name string

Peggy Manders

1

1 reference

5 December 2017

Louk V. A M. Beex

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14601081

29 March 2024

Vivianne C. G. Tjan-Heijnen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14601081

29 March 2024

language of work or name

English

0 references

publication date

1 November 2003

1 reference

5 December 2017

15 November 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14601081

full work available at URL

29 March 2024

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcncr.11764

1 reference

https://onlinelibrary.wiley.com/doi/full/10.1002/cncr.11764

29 March 2024

1 reference

29 March 2024

1 reference

5 December 2017

98

1 reference

5 December 2017

10

1 reference

5 December 2017

2125-2132

1 reference

Chemotherapy of metastatic breast cancer: what to expect in 2001 and beyond

5 December 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11764

7 January 2021

Tamoxifen in the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11764

7 January 2021

Steroid hormone receptors in breast cancer management

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11764

7 January 2021

When is a tumor marker ready for prime time? A case study of c-erbB-2 as a predictive factor in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11764

7 January 2021

Predictive factors for response to chemotherapy in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11764

7 January 2021

Angiogenesis in cancer, vascular, rheumatoid and other disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11764

7 January 2021

Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11764

7 January 2021

Contribution of vascular endothelial growth factor to the Nottingham prognostic index in node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11764

7 January 2021

Thrombospondin-1 and -2 in node-negative breast cancer: correlation with angiogenic factors, p53, cathepsin D, hormone receptors and prognosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11764

7 January 2021

The prognostic value of vascular endothelial growth factor in 574 node-negative breast cancer patients who did not receive adjuvant systemic therapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11764

7 January 2021

Correlation of Vascular Endothelial Growth Factor Content With Recurrences, Survival, and First Relapse Site in Primary Node-Positive Breast Carcinoma After Adjuvant Treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11764

7 January 2021

EORTC Receptor and Biomarker Study Group Report: a sandwich enzyme-linked immunosorbent assay for vascular endothelial growth factor in blood and tumor tissue extracts

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11764

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11764

7 January 2021

Hormone receptors in primary and advanced breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11764

7 January 2021

The value of estrogen and progesterone receptors in the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11764

7 January 2021

Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11764

7 January 2021

Steroid receptors and other prognostic factors in primary breast cancer

4

1 reference

The role of angiogenesis in tumor growth

29 March 2024

11

1 reference

Presalvage prostate-specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy

29 March 2024

22

1 reference

29 March 2024

Identifiers

DOI

10.1002/CNCR.11764

1 reference

5 December 2017

1 reference